2CdA chemotherapy and rituximab in the treatment of marginal zone lymphoma

Revised Response Criteria for Malignant Lymphoma

Bruce D. Cheson, Beate Pfistner, Malik E. Juweid et al. · Journal of Clinical Oncology · 2007 · 4.4K citations · Full text

Medicine, Oncology, Pathology +15

A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma

Blood · 1997 · 2.5K citations · Full text

Medicine, Oncology, Pathology +11

Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type

A. Conconi · Blood · 2003 · 402 citations · Full text

Medicine, Immunology, Oncology +9

Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients

Françoise Berger, Pascale Felman, Catherine Thiéblemont et al. · Blood · 2000 · 294 citations

Medicine, Hematology, Oncology +10

Clinical Activity of Rituximab in Gastric Marginal Zone Non-Hodgkin's Lymphoma Resistant to or Not Eligible for Anti–<i>Helicobacter Pylori</i> Therapy

Giovanni Martinelli, Daniele Laszlò, Andrés J.M. Ferreri et al. · Journal of Clinical Oncology · 2005 · 267 citations

Medicine, Oncology, Pharmacotherapy +15